-
Watch List: Sprint Corporation (NYSE:S), Vericel Corporation (NASDAQ:VCEL), Ocean Power Technologies (NASDAQ:OPTT), Himax Technologies (ADR) (NASDAQ:HIMX), Bellatrix Exploration (NYSE:BXE)
On Wednesday shares of Sprint Corporation (NYSE:S) closed at $4.84. Company’s EPS growth for next 5 years is recorded as 18.15%. Sprint Corporation (NYSE:S) reported its fiscal fourth-quarter 2014 earnings, with the company reporting a net addition of 1.2 million subscribers, the highest total in three years. Even so, there are still red flags that…
-
Stocks in News: Vericel Corporation (NASDAQ:VCEL), Himax Technologies (ADR) (NASDAQ:HIMX), Granite Construction Incorporated (NYSE:GVA), Oaktree Capital Group (NYSE:OAK), Avon Products (NYSE:AVP)
On Monday shares of Vericel Corporation (NASDAQ:VCEL) closed at $3.76. Company’s sales growth for last 5 years was 210.40% Vericel Corporation (NASDAQ:VCEL) announced that it will present a corporate update at the 14th Annual Needham Healthcare Conference at 4:20 pm Eastern time on Wednesday, April 15, at the Westin Grand Central Hotel in New York.…
-
Active Stocks: Vericel Corporation (NASDAQ:VCEL), Citigroup Inc. (NYSE:C), Douglas Emmett Inc (NYSE:DEI), Farmland Partners Inc. (NYSEMKT:FPI), Lorillard (NYSE:LO)
On Monday shares of Vericel Corporation (NASDAQ:VCEL) closed at $3.73. Company’s sales growth for last 5 years was 210.40%.On March 25, Vericel Corporation (Nasdaq:VCEL) reported that positive results from the three-year extension of the Phase 3 SUMMIT study with MACI™ (matrix-applied characterized autologous cultured chondrocytes) were presented at the annual meeting of the American Association…
-
Why These Are Hot: Vericel Corporation (NASDAQ:VCEL), Brightcove Inc. (NASDAQ:BCOV), Rhino Resource Partners LP (NYSE:RNO), InterCloud Systems (NASDAQ:ICLD), Higher One Holdings (NYSE:ONE)
On January 29, Vericel Corporation (NASDAQ:VCEL) announced the completion of patient enrollment in the company’s Phase 2b ixCELL-DCM clinical trial evaluating ixmyelocel-T for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM). Top-line results from this study are expected around the end of the first quarter of 2016. On Friday shares of…
-
Traders Are Gambling on: Vericel Corporation (NASDAQ:VCEL), CBOE Holdings (NASDAQ:CBOE), Intricon Corp. (NASDAQ:IIN), British American Tobacco plc (NYSEMKT:BTI), Harris Corporation (NYSE:HRS)
On 29 January, Vericel Corporation (NASDAQ:VCEL), announced the completion of patient enrollment in the company’s Phase 2b ixCELL-DCM clinical trial evaluating ixmyelocel-T for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (DCM). Top-line results from this study are expected around the end of the first quarter of 2016. On Friday shares of…
-
Hot Runners: LRAD Corporation (NASDAQ:LRAD), Vericel Corporation (NASDAQ:VCEL), Microsemi Corporation (NASDAQ:MSCC), Live Nation Entertainment (NYSE:LYV), Target Corp. (NYSE:TGT)
On February 5, LRAD Corporation (NASDAQ:LRAD) reported financial results for the first quarter of fiscal 2015, ended December 31, 2014. Revenues: First quarter 2015 revenues grew by $562,000 or 15% to $4.4 million, compared to $3.8 million in the first quarter of 2014, driven by continued revenue growth in international markets. On Friday shares of…
-
Biotech Gainers in Spotlight: Genetic Technologies Limited (NASDAQ:GENE), Cambrex Corporation. (NYSE:CBM), Portola Pharmaceuticals (NASDAQ:PTLA), Coherus Biosciences (NASDAQ:CHRS), Vericel Corporation (NASDAQ:VCEL)
On 29 January, Genetic Technologies Limited (NASDAQ: GENE) reported that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus® to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in…
-
Watch 5 Stocks: SandRidge Energy (NYSE:SD), Vericel Corporation (NASDAQ:VCEL), PharMerica Corporation (NYSE:PMC), Mavenir Systems (NYSE:MVNR), NBT Bancorp (NASDAQ:NBTB)
On 5 February, SandRidge Energy, Inc. (NYSE:SD) announced the appointment of J. Mike Stice to the board of directors. On Friday shares of SandRidge Energy, Inc. (NYSE:SD) closed at $2.19. Company’s sales growth for last 5 years was 10.90% and EPS growth for next 5 years is recorded as 30.90%. On 29 January, Vericel Corporation…